Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Kansai Medical University |
---|---|
Information provided by: | Kansai Medical University |
ClinicalTrials.gov Identifier: | NCT00436111 |
The purpose of this study is to clarify the nature of macroprolactin which has recently been highlighted because of the high prevalence and a diagnostic pitfall of hyperprolactinemia. The results of this study are beneficial for the patients to whom unnecessary medications and unnecessary radiological examinations have been performed. We used the remained serum samples taken for routine prolactin determination during the past several years. Since the blood was basically taken to examine the causes of hyperprolactinemia and only remained serum samples were used for this study, the Ethics Committee of Kobe City General Hospital judged that it was not required to obtain approval number.
Condition |
---|
Hyperprolactinemia |
Study Type: | Observational |
Study Design: | Natural History, Longitudinal, Defined Population, Retrospective Study |
Genders Eligible for Study: | Both |
Inclusion Criteria: - Clinical diagnosis of hyperprolactinemia
Japan | |
Kansai Medical University | |
Osaka, Japan, 570-8506 |
Study Chair: | Naoki Hattori, M.D., Ph.D. | Department of Pharmacology, Kansai Medical University |
Study ID Numbers: | KK-2007-1 |
Study First Received: | February 15, 2007 |
Last Updated: | February 15, 2007 |
ClinicalTrials.gov Identifier: | NCT00436111 History of Changes |
Health Authority: | Japan: Ministry of Education, Culture, Sports, Science and Technology |
hyperprolactinemia autoantibody |
Hypothalamic Diseases Autoantibodies Pituitary Diseases Galactorrhoea-Hyperprolactinaemia Endocrine System Diseases |
Central Nervous System Diseases Hyperprolactinemia Endocrinopathy Brain Diseases |
Hypothalamic Diseases Hyperpituitarism Pituitary Diseases Nervous System Diseases |
Endocrine System Diseases Central Nervous System Diseases Hyperprolactinemia Brain Diseases |